23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.07%
Revenue growth exceeding 1.5x Insurance - Life median of 0.95%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
23.07%
Gross profit growth exceeding 1.5x Insurance - Life median of 0.97%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
-5.46%
Negative EBIT growth while Insurance - Life median is 3.09%. Seth Klarman would check if external or internal factors caused the decline.
-5.46%
Negative operating income growth while Insurance - Life median is 8.48%. Seth Klarman would check if structural or cyclical issues are at play.
-6.28%
Negative net income growth while Insurance - Life median is 2.18%. Seth Klarman would investigate factors dragging net income down.
-6.29%
Negative EPS growth while Insurance - Life median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-6.29%
Negative diluted EPS growth while Insurance - Life median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
52.94%
OCF growth of 52.94% while Insurance - Life is zero. Walter Schloss might see a modest positive difference, which can compound over time.
52.94%
FCF growth of 52.94% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
122.00%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 27.82%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
43.37%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 28.02%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
25.44%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 9.78%. Joel Greenblatt might see a short-term competitive advantage at play.
109.96%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 0.71% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
32.08%
OCF/share CAGR of 32.08% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
84.72%
3Y OCF/share growth of 84.72% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
13.92%
Net income/share CAGR of 13.92% while Insurance - Life median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
517.67%
5Y net income/share CAGR > 1.5x Insurance - Life median of 38.27%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
34.15%
3Y net income/share CAGR > 1.5x Insurance - Life median of 0.49%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
70.52%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 43.48% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
70.95%
5Y equity/share CAGR > 1.5x Insurance - Life median of 40.64%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
43.28%
3Y equity/share CAGR > 1.5x Insurance - Life median of 21.58%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.07%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
-0.36%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
0.67%
Below 50% of Insurance - Life median. Jim Chanos suspects deeper issues blocking net worth accumulation.
-4.83%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
4.57%
SG&A growth of 4.57% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.